Tim Anderson

3 results

Novartis estimates that only 600 patients a year would be eligible for its new $375,000 therapy. Photograph: Vivek Prakash/Reuters

Novartis’s new gene-modifying cancer therapy’s $475,000 (€399,100) per patient sticker price has drawn fire from advocate groups calling for cheaper d(...)

Improving margins and growing demand for new drugs lifted GlaxoSmithKline’s underlying earnings a better-than-expected 14 per cent in the first quart(...)

  Tim Anderson will be in the Electrolux Secret Ingredient demo kitchen at Taste of Dublin next week

Kitchen kit for ambitious home cooks Visitors to Taste of Dublin next week might like to visit the Electrolux Secret Ingredient area, where Tim (...)